Full Text View
Tabular View
No Study Results Posted
Related Studies
A Repeat Dose Positron Emission Tomography Study With GSK1144814 (NK1 NK3 PET)
This study has been completed.
Study NCT01209039   Information provided by GlaxoSmithKline

First Received on August 30, 2010.   Last Updated on January 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Healthy Volunteer
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
GSK1144814
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services